H Pols, J Zandergen, C de Loof, I Fernandez, E Griez
{"title":"氟伏沙明对惊恐症状的临床影响。","authors":"H Pols, J Zandergen, C de Loof, I Fernandez, E Griez","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>In a double-blind randomized placebo-controlled cross-over design trial, the effects of a 4 week fluvoxamine versus a 4 week placebo treatment regimen on panic symptomatology were studied. Fluvoxamine seems to have specific antipanic properties, as a significant decrease in the number of panic attacks was observed. Other components of the disorder, like free-floating anxiety and avoidance behavior were not influenced during the short 4 week treatment period.</p>","PeriodicalId":75415,"journal":{"name":"Acta psychiatrica Belgica","volume":"93 3","pages":"169-77"},"PeriodicalIF":0.0000,"publicationDate":"1993-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical effects of fluvoxamine on panic symptomatology.\",\"authors\":\"H Pols, J Zandergen, C de Loof, I Fernandez, E Griez\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In a double-blind randomized placebo-controlled cross-over design trial, the effects of a 4 week fluvoxamine versus a 4 week placebo treatment regimen on panic symptomatology were studied. Fluvoxamine seems to have specific antipanic properties, as a significant decrease in the number of panic attacks was observed. Other components of the disorder, like free-floating anxiety and avoidance behavior were not influenced during the short 4 week treatment period.</p>\",\"PeriodicalId\":75415,\"journal\":{\"name\":\"Acta psychiatrica Belgica\",\"volume\":\"93 3\",\"pages\":\"169-77\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1993-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta psychiatrica Belgica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta psychiatrica Belgica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Clinical effects of fluvoxamine on panic symptomatology.
In a double-blind randomized placebo-controlled cross-over design trial, the effects of a 4 week fluvoxamine versus a 4 week placebo treatment regimen on panic symptomatology were studied. Fluvoxamine seems to have specific antipanic properties, as a significant decrease in the number of panic attacks was observed. Other components of the disorder, like free-floating anxiety and avoidance behavior were not influenced during the short 4 week treatment period.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
